N-(2,4-Dichlorobenzyl)hydroxylamine hydrochloride, 95.0%, 1g

(R)-1-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2-piperidinecarboxylic Acid>98.0%(HPLC)(T)5g

GC capillary column ROTI®Cap-1701, 30 m, 0.32 mm, 1.00 µm, 1 Piece(s)

6-Bromobenzo[d]isothiazole-3-carboxylic acid, 95.0%, 250mg

4-Methylthiazole-2-carbonitrile, 95.0%, 5g

N-methyl-6-nitrobenzo[d]thiazol-2-amine, 98%, 1g

3-Methoxyazetidine-1-sulfonamide, 98+%, 250mg

(11bS)?-N,?N-?Dipropyl-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin-?4-?amine, 97%, 250mg

1,3-Diethyl-1h-pyrazole-5-carboxylic acid, 98+%, 100mg

(1-(3-Bromophenyl)cyclopropyl)methanol, 98%, 5g

2-Bromo-6-fluoro-4-hydroxy-benzaldehyde, 96%, 500mg

4-Difluoromethoxy-3-nitrotoluene, 1g

Lithium 2-(6-(1H-imidazol-1-yl)pyridazine-3-carboxamido)-4,5-difluorobenzoate, 98.0%, 10mg